Dysregulation of the Akt/mTOR signaling pathway has been associated with AD pathology in both in vivo animal models of AD and in postmortem brain tissues from AD patients (21, 42, 69, 70, 71). This evidence concerns the gene AKT1 and Alzheimer disease.